GO:0099573 glutamatergic postsynaptic density: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0099573 glutamatergic postsynaptic density is the postsynaptic specialization of a glutamatergic excitatory synapse, an electron-dense protein network that organizes neurotransmitter receptors and signaling enzymes.
• The glutamatergic postsynaptic density is a dynamic, scaffold-rich compartment built from MAGUKs, Homer, Shank, GKAP, PSD-95 and glutamate receptors, and it couples receptor activation to downstream signaling.
• Dysregulation of postsynaptic density proteins is implicated in schizophrenia, treatment-resistant schizophrenia, behavioral disorders and stress-related programming of glutamatergic synapses.
• Homer proteins and metabotropic glutamate receptor 5 (mGlu5) are key postsynaptic density organizers whose expression is altered by early life stress and in psychiatric illness.
• BDNF signaling and neurotrophic factor pathways influence glutamatergic postsynaptic density composition and synaptic plasticity, linking the structure to depression and neurodegeneration.
• The postsynaptic density is studied with proteomics, imaging, electrophysiology, transcriptomics and CRISPR-based models, and it is a target for novel antipsychotic and neuropsychiatric therapeutic strategies.
Description
The glutamatergic postsynaptic density (GO:0099573) is the postsynaptic specialization of a glutamatergic excitatory synapse, defined in QuickGO as the postsynaptic specialization of a glutamatergic excitatory synapse. It is a microscopic, electron-dense protein assembly that sits immediately beneath the postsynaptic membrane and concentrates neurotransmitter receptors, scaffolding proteins, kinases, phosphatases and cytoskeletal elements. Because glutamatergic synapses carry most fast excitatory transmission in the mammalian brain, the molecular composition of the postsynaptic density determines how strongly a neuron responds to glutamate and how that response is converted into intracellular signals. Researchers study GO:0099573 to understand synaptic plasticity, learning and memory, and the synaptic basis of neuropsychiatric disease. The postsynaptic density is not a static structure; its protein constituents are trafficked, phosphorylated and degraded in response to activity, and its remodeling is central to long-term potentiation and long-term depression. Consequently, the term is a hub for neuroscience, pharmacology and disease-model research, and it is increasingly interrogated with CRISPR screens, proteomics and imaging.
glutamatergic postsynaptic density At A Glance
| GO ID | GO:0099573 |
|---|---|
| GO term | glutamatergic postsynaptic density |
| Ontology | cellular_component |
| Synonym | postsynaptic specialization, glutamatergic neuron-to-neuron synapse |
| Definition | The post-synaptic specialization of a glutamatergic excitatory synapse. |
| Major function | Organizes glutamate receptors, scaffolds and signaling enzymes at excitatory postsynapses to support synaptic transmission and plasticity. |
| Key protein families | MAGUKs (PSD-95/SAP90), Homer, Shank, GKAP/SAPAP, AMPA and NMDA receptor subunits, mGlu5. |
| Associated disease areas | Schizophrenia, treatment-resistant schizophrenia, behavioral disorders, stress-related synaptic programming, depression and neurodegeneration. |
| Research methods | Proteomics, imaging, electrophysiology, transcriptomics, CRISPR knockout and knock-in models. |
What Is GO:0099573?
In plain terms, GO:0099573 describes the dense, specialized protein machine on the receiving side of a glutamatergic excitatory synapse. It is the postsynaptic specialization of a glutamatergic excitatory synapse, a cellular component that clusters glutamate receptors and their associated signaling and scaffolding proteins at the postsynaptic membrane. The QuickGO synonym postsynaptic specialization, glutamatergic neuron-to-neuron synapse emphasizes that this structure is characteristic of neuron-to-neuron glutamatergic synapses. Functionally, it is the site where glutamate released from the presynaptic terminal is detected and where the resulting signal is amplified, integrated and transmitted to intracellular pathways.
Why Is glutamatergic postsynaptic density Important in Cell Biology?
GO:0099573 matters because the glutamatergic postsynaptic density is the principal signal-processing compartment of excitatory synapses, and its molecular composition directly shapes synaptic strength, plasticity and behavior. Alterations in postsynaptic density proteins have been repeatedly linked to schizophrenia and other behavioral disorders, and the structure is considered a translational target for antipsychotic drug development. Because it integrates receptor, scaffold and signaling components, the postsynaptic density is also a practical entry point for CRISPR-based functional genomics, proteomic mapping and drug discovery in neuropsychiatric disease.
• It is the core postsynaptic specialization of glutamatergic excitatory synapses and the site of fast excitatory transmission.
• It concentrates NMDA, AMPA and metabotropic glutamate receptors together with their downstream effectors.
• Its protein composition is dynamically remodeled during synaptic plasticity, learning and memory.
• Postsynaptic density protein dysfunction is implicated in schizophrenia and other behavioral disorders.
• Homer and mGlu5 expression in the postsynaptic density is altered by early life stress, linking the structure to stress programming.
• BDNF signaling influences glutamatergic synaptic structure and is relevant to depression, neurodegeneration and brain cancer.
• The postsynaptic density is a target for novel antipsychotic and treatment-resistant schizophrenia strategies.
• It is a tractable model for studying protein-protein interaction networks at synapses.
• CRISPR and proteomic methods now allow systematic interrogation of postsynaptic density gene function.
• Radiation and environmental stressors can leave measurable signatures on postsynaptic density composition.
Core Biology of GO:0099573 glutamatergic postsynaptic density
What Happens During glutamatergic postsynaptic density assembly and signaling?
In simple terms: Glutamate released from the presynaptic neuron lands on receptors in the postsynaptic density, and the density turns that chemical message into a cellular response.
At a glutamatergic synapse, presynaptic glutamate release activates ionotropic and metabotropic receptors embedded in the postsynaptic density. The density positions these receptors opposite the release site and couples them to scaffolding proteins and signaling enzymes, so that receptor activation is rapidly translated into ion flux and second-messenger cascades. This arrangement supports fast excitatory transmission and provides the structural basis for activity-dependent synaptic plasticity.
Receptor anchoring and scaffold assembly
In simple terms: Scaffold proteins act like molecular Velcro that hold glutamate receptors and signaling enzymes in the right place.
MAGUK family proteins such as PSD-95 bind the cytoplasmic tails of NMDA receptor subunits and organize a larger scaffold that includes GKAP/SAPAP, Shank and Homer. Homer proteins further cross-link metabotropic glutamate receptors such as mGlu5 to intracellular calcium channels and signaling complexes, stabilizing the postsynaptic density architecture. This scaffold assembly is essential for clustering receptors at the postsynaptic membrane and for efficient signal transduction.
Activity-dependent remodeling and plasticity
In simple terms: When synapses are used heavily or weakly, the postsynaptic density changes its protein composition to strengthen or weaken the connection.
The postsynaptic density is a dynamic structure whose protein composition changes during long-term potentiation and long-term depression. Activity-dependent trafficking, phosphorylation and degradation of postsynaptic density components alter receptor number and signaling output, which underlies synaptic plasticity. Dysregulation of these remodeling events has been linked to abnormal dendritic spine morphology and behavioral disorders.
Stress and neurotrophic regulation of the postsynaptic density
In simple terms: Stress hormones and growth factors can retune the postsynaptic density, changing how synapses respond to glutamate.
Early life stress programs the topographic expression of mGlu5 receptors and Homer proteins in the glutamatergic postsynaptic density, suggesting that environmental experience leaves lasting marks on this structure. Neurotrophic factors such as BDNF modulate glutamatergic synaptic function and are implicated in depression, neurodegeneration and brain cancer, providing a signaling link between growth factor pathways and postsynaptic density organization. These findings position the postsynaptic density as an interface between experience, neurotrophic signaling and synaptic function.
Key Genes Involved in GO:0099573 glutamatergic postsynaptic density
The following genes and proteins are established components or regulators of the glutamatergic postsynaptic density and are commonly studied in synaptic and neuropsychiatric research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DLG4 (PSD-95/SAP90) | MAGUK scaffold that binds NMDA receptors and organizes the postsynaptic density | Core marker and scaffold for postsynaptic density assembly and receptor clustering |
| GRIN1 (NR1) | Obligatory NMDA receptor subunit anchored at the postsynaptic density | Target for studying excitatory transmission and plasticity |
| GRIN2A (NR2A) | NMDA receptor subunit that interacts with postsynaptic scaffolds | Relevant to synaptic plasticity and neuropsychiatric models |
| GRIN2B (NR2B) | NMDA receptor subunit enriched in postsynaptic density signaling complexes | Studied in developmental plasticity and disease models |
| GRIA1 (GluA1) | AMPA receptor subunit that mediates fast excitatory transmission | Key readout for synaptic strength and plasticity |
| GRIA2 (GluA2) | AMPA receptor subunit influencing calcium permeability and trafficking | Used to study receptor composition and synaptic function |
| GRM5 (mGlu5) | Metabotropic glutamate receptor linked to Homer and postsynaptic signaling | Implicated in stress programming and psychiatric disorders |
| HOMER1 | Scaffold that couples mGlu5 and other proteins to postsynaptic signaling | Central to postsynaptic density signal transduction and behavior |
| HOMER2 | Homer family scaffold involved in postsynaptic complex assembly | Studied in synaptic signaling and pharmacotherapy research |
| HOMER3 | Homer family protein contributing to postsynaptic density organization | Relevant to glutamatergic signaling and behavioral studies |
| SHANK1 | Scaffold that links receptor complexes to the cytoskeleton | Model gene for postsynaptic density assembly and disease |
| SHANK2 | Postsynaptic scaffold protein in glutamatergic synapses | Associated with synaptic and behavioral disorder research |
| SHANK3 | Scaffold protein important for postsynaptic density integrity | Widely studied in neurodevelopmental and psychiatric models |
| DLGAP1 (GKAP/SAPAP) | Connects PSD-95 to Shank and downstream signaling | Used to map postsynaptic density protein interaction networks |
| BDNF | Neurotrophic factor that modulates glutamatergic synaptic function | Linked to depression, neurodegeneration and brain cancer research |
| CAMK2A | Calcium/calmodulin-dependent kinase enriched at postsynaptic densities | Key effector of activity-dependent synaptic plasticity |
| ARC | Activity-regulated cytoskeletal protein involved in synaptic remodeling | Marker of activity-dependent postsynaptic density remodeling |
| NOS1 | Neuronal nitric oxide synthase coupled to postsynaptic scaffolds | Studied in synaptic signaling and neurotoxicity models |
How Is glutamatergic postsynaptic density Regulated?
The glutamatergic postsynaptic density is regulated at multiple levels. Activity-dependent trafficking, phosphorylation and degradation of scaffold and receptor proteins remodel the structure during synaptic plasticity. Homer proteins regulate the coupling of mGlu5 to intracellular signaling and are themselves subject to expression changes after early life stress. Neurotrophic signaling through BDNF modulates glutamatergic synaptic function and provides an extrinsic layer of control over postsynaptic density composition and plasticity. In addition, environmental stressors such as radiation can leave measurable signatures on postsynaptic density protein networks, indicating that the structure responds to diverse physiological and pathological inputs.
glutamatergic postsynaptic density and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DLG4 (PSD-95) | Schizophrenia and synaptic plasticity dysfunction | Neuronal knockout and rescue with tagged knock-in |
| GRM5 (mGlu5) | Early life stress programming and psychiatric risk | Stress-exposed conditional knockout or overexpression models |
| HOMER1 | Postsynaptic signaling in behavioral disorders | Homer1 knockout and point-mutation models |
| SHANK3 | Neurodevelopmental and behavioral disorder biology | Knockout and patient-mutation knock-in neurons |
| BDNF | Depression, neurodegeneration and brain cancer | Overexpression and conditional knockout models |
Schizophrenia and behavioral disorders
Dysfunctions of glutamatergic postsynaptic density proteins have been linked to impaired synaptic plasticity and abnormal dendritic spine morphology, and these alterations are relevant to schizophrenia and other behavioral disorders. Translational work has highlighted the glutamatergic postsynaptic density as a source of new antipsychotic targets, including for treatment-resistant schizophrenia. These findings support the view that postsynaptic density proteins are not merely markers but potential causal contributors to psychiatric pathophysiology.
Early life stress and stress-related programming
Early life stress alters the topographic gene expression of mGlu5 receptors and Homer proteins in the glutamatergic postsynaptic density, suggesting that adverse early experiences can program excitatory synapse composition. Because Homer proteins organize postsynaptic signaling complexes, such changes may contribute to lasting behavioral vulnerability. This has motivated research into postsynaptic density proteins as mediators of stress-related psychiatric risk.
Depression, neurodegeneration and brain cancer
BDNF is a neurotrophic factor with physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer, and it modulates glutamatergic synaptic function. Because BDNF signaling intersects with postsynaptic density organization, alterations in this pathway may influence disease-relevant synaptic phenotypes. This connection makes the glutamatergic postsynaptic density a candidate interface for neurotrophic therapeutic strategies.
Environmental and radiation-induced synaptic stress
Postsynaptic density radiation signatures have been described following space irradiation, indicating that the structure can register environmental stress at the molecular level. Such signatures may serve as readouts of synaptic damage or adaptation in extreme environments. This expands the disease and physiology relevance of GO:0099573 beyond classical neuropsychiatric conditions.
From glutamatergic postsynaptic density-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a postsynaptic density scaffold impair excitatory transmission? | CRISPR knockout of DLG4 or SHANK family genes in neurons |
| Does a disease-associated point mutation alter receptor clustering? | CRISPR point-mutation knock-in of the endogenous locus |
| Can a fluorescent tag reveal postsynaptic density dynamics? | Tagged knock-in of PSD-95 or Homer |
| Does overexpression of a postsynaptic density protein change spine morphology? | CRISPR overexpression or cDNA overexpression in neurons |
| Which genes regulate postsynaptic density composition under stress? | CRISPR library screening combined with stress paradigms |
| How does BDNF signaling reshape glutamatergic synapses? | BDNF overexpression or knockout with synaptic readouts |
How to Study the glutamatergic postsynaptic density Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | Protein composition of postsynaptic density fractions | Mapping scaffold and receptor networks |
| Electron microscopy | Ultrastructure and density morphology | Visualizing postsynaptic specializations |
| Electrophysiology | Excitatory synaptic transmission and plasticity | Functional validation of CRISPR perturbations |
| Confocal and super-resolution imaging | Receptor clustering and spine morphology | Linking protein localization to synaptic structure |
| Transcriptomics | Gene expression changes in postsynaptic density networks | Stress and disease modeling |
| CRISPR knockout | Loss-of-function effects on synaptic phenotypes | Causal gene testing in neurons |
| CRISPR knock-in | Tagged or mutant protein behavior at endogenous loci | Disease mutation modeling |
| CRISPR library screening | Systematic identification of postsynaptic density regulators | Functional genomics of synaptic composition |
Proteomic mapping of the postsynaptic density
Biochemical fractionation and mass spectrometry have been used to define the protein composition of the postsynaptic density at glutamatergic synapses. These approaches identify scaffold, receptor and signaling proteins and reveal how the structure changes across conditions. Proteomic signatures can also detect environmental effects such as radiation exposure.
Imaging and electrophysiology
Light and electron microscopy visualize postsynaptic density morphology and dendritic spine structure, while electrophysiology measures excitatory synaptic transmission and plasticity. Combining imaging with electrophysiology links molecular composition to functional output. These methods are central to validating CRISPR-based perturbations of postsynaptic density genes.
Transcriptomic and topographic expression analysis
Topographic gene expression analysis of mGlu5 receptors and Homer proteins has been used to study how early life stress programs the glutamatergic postsynaptic density. Transcriptomic profiling can reveal region-specific and cell-type-specific changes in postsynaptic density gene networks. Such data help prioritize candidate genes for functional testing.
CRISPR functional genomics
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of postsynaptic density genes in neurons and animal models. Library screening can systematically identify regulators of postsynaptic density composition and synaptic phenotypes. These approaches connect genetic variation to synaptic and behavioral outcomes.
How CRISPR Can Be Used to Study GO:0099573 glutamatergic postsynaptic density
Knockout
CRISPR knockout of postsynaptic density genes such as DLG4, SHANK3 or HOMER1 allows researchers to test whether a candidate protein is required for receptor clustering, excitatory transmission and plasticity. Knockout neurons and animal models can be assayed by electrophysiology, imaging and proteomics to define loss-of-function phenotypes. These models are foundational for linking postsynaptic density genes to behavior and disease.
Point Mutation
CRISPR point-mutation knock-in introduces disease-associated or phospho-site mutations into endogenous postsynaptic density genes, preserving native regulatory context. This is valuable for testing whether a specific amino acid change alters receptor binding, scaffold assembly or synaptic plasticity. Point-mutation models help distinguish causal variants from passenger changes in neuropsychiatric genetics.
Knock-in
Tagged knock-in of postsynaptic density proteins such as PSD-95 or Homer enables live imaging and biochemical purification of native complexes. Knock-in of reporter or affinity tags avoids overexpression artifacts and reveals endogenous localization and dynamics. These models are widely used to study postsynaptic density assembly and remodeling.
Overexpression
CRISPR-based overexpression or cDNA overexpression of postsynaptic density genes can test gain-of-function effects on spine morphology, receptor clustering and synaptic strength. Overexpression models are useful for probing dosage-sensitive pathways implicated in behavioral disorders. They complement knockout and knock-in approaches in a comprehensive functional pipeline.
How EDITGENE Supports glutamatergic postsynaptic density Research
Researchers studying glutamatergic postsynaptic density-related genes often need to determine whether a candidate gene is causally involved in synaptic assembly, receptor clustering or disease-relevant phenotypes. EDITGENE provides CRISPR-based cell models and screening services that let teams move from candidate lists to validated mechanisms in a controlled, reproducible workflow.
Contact EDITGENE today to design your custom CRISPR model for glutamatergic postsynaptic density research.
Frequently Asked Questions About glutamatergic postsynaptic density
What is GO:0099573 glutamatergic postsynaptic density?
GO:0099573 is the cellular component ontology term for the postsynaptic specialization of a glutamatergic excitatory synapse, an electron-dense protein network that organizes glutamate receptors and signaling enzymes.
What genes are involved in the glutamatergic postsynaptic density?
Key genes include DLG4 (PSD-95), GRIN1, GRIN2A, GRIN2B, GRIA1, GRIA2, GRM5, HOMER1-3, SHANK1-3, DLGAP1, CAMK2A, ARC and NOS1.
Why is the glutamatergic postsynaptic density important for synaptic plasticity?
It clusters glutamate receptors and signaling proteins in a dynamic structure that is remodeled during long-term potentiation and long-term depression, which are cellular correlates of learning and memory.
How is the glutamatergic postsynaptic density linked to schizophrenia?
Dysfunctions of postsynaptic density proteins are associated with impaired synaptic plasticity and abnormal dendritic spine morphology relevant to schizophrenia and other behavioral disorders.
What role do Homer proteins play in the postsynaptic density?
Homer proteins scaffold metabotropic glutamate receptors such as mGlu5 to intracellular signaling complexes and help organize the glutamatergic postsynaptic density.
How does early life stress affect the glutamatergic postsynaptic density?
Early life stress alters the topographic expression of mGlu5 receptors and Homer proteins in the postsynaptic density, suggesting lasting programming of excitatory synapse composition.
What methods are used to study the glutamatergic postsynaptic density?
Common methods include mass spectrometry proteomics, electron microscopy, electrophysiology, imaging, transcriptomics and CRISPR-based functional genomics.
Can CRISPR be used to model postsynaptic density gene function?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of postsynaptic density genes in neurons and animal models.
Is the glutamatergic postsynaptic density a drug target?
Translational research has highlighted the glutamatergic postsynaptic density as a source of new antipsychotic targets, including for treatment-resistant schizophrenia.
What is the difference between the postsynaptic density and the postsynaptic membrane?
The postsynaptic density is a protein-rich specialization beneath the postsynaptic membrane that concentrates receptors and scaffolds, whereas the membrane itself is the lipid bilayer containing those receptors.
Conclusion
GO:0099573 glutamatergic postsynaptic density is a central cellular component of excitatory synapses, integrating glutamate receptors, scaffolds and signaling enzymes into a dynamic machine that shapes synaptic transmission and plasticity. Its dysfunction is implicated in schizophrenia, behavioral disorders, stress-related programming and neurotrophic disease pathways, making it a high-value target for mechanistic and translational research. Advances in proteomics, imaging and CRISPR functional genomics now allow researchers to dissect postsynaptic density gene function with unprecedented precision. Continued work on this structure promises new insights into brain function and new therapeutic strategies for neuropsychiatric disease.
References
- 1. Kennedy MB. 1997. The postsynaptic density at glutamatergic synapses.. Trends Neurosci 20(6):264-8 PMID: 9185308
- 2. de Bartolomeis A et al.. 2014. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.. Mol Neurobiol 49(1):484-511 PMID: 23999870
- 3. Colucci-D'Amato L et al.. 2020. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.. Int J Mol Sci 21(20) PMID: 33096634
- 4. Boeckers TM. 2006. The postsynaptic density.. Cell Tissue Res 326(2):409-22 PMID: 16865346
- 5. Buonaguro EF et al.. 2020. Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins.. Prog Neuropsychopharmacol Biol Psychiatry 96:109725 PMID: 31404590
- 6. de Bartolomeis A et al.. 2019. Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia.. Neurosci Biobehav Rev 107:795-827 PMID: 31461641
- 7. de Bartolomeis A et al.. 2003. The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy.. Psychopharmacol Bull 37(3):51-83 PMID: 14608240
- 8. Impey S et al.. 2023. Postsynaptic density radiation signature following space irradiation.. Front Physiol 14:1215535 PMID: 37440997
